Free Trial

Basilea Pharmaceutica (BPMUF) Short Interest Ratio & Short Volume

Basilea Pharmaceutica logo
$52.83
0.00 (0.00%)
(As of 11/4/2024 ET)

Basilea Pharmaceutica Short Interest Data

Basilea Pharmaceutica (BPMUF) has a short interest of 30,400 shares. This marks a -0.33% decrease in short interest from the previous month. The short interest ratio (days to cover) is 304.0, indicating that it would take 304.0 days of the average trading volume of 117 shares to cover all short positions.

Current Short Interest
30,400 shares
Previous Short Interest
30,500 shares
Change Vs. Previous Month
-0.33%
Dollar Volume Sold Short
$1.61 million
Short Interest Ratio
304.0 Days to Cover
Last Record Date
October 15, 2024
Today's Trading Volume
0 shares
Average Trading Volume
117 shares
Today's Volume Vs. Average
0%
Short Selling Basilea Pharmaceutica?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Basilea Pharmaceutica and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BPMUF Short Interest Over Time

BPMUF Days to Cover Over Time

BPMUF Percentage of Float Shorted Over Time

Basilea Pharmaceutica Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/202430,400 shares $1.61 million -0.3%N/A304 $52.83
9/30/202430,500 shares $1.56 million -2.2%N/A305 $51.26
9/15/202431,200 shares $1.60 million No ChangeN/A0 $51.26
8/31/202431,200 shares $1.60 million +0.3%N/A0 $51.26
8/15/202431,100 shares $1.46 million -57.0%N/A0 $47.00
7/31/202472,300 shares $3.40 million -14.4%N/A723 $47.00
7/15/202484,500 shares $4.07 million -8.9%N/A0 $48.15
6/30/202492,800 shares $4.47 million +3.3%N/A0 $48.15
6/15/202489,800 shares $4.32 million +19.9%N/A0 $48.15
5/31/202474,900 shares $3.61 million -9.1%N/A749 $48.15
5/15/202482,400 shares $3.66 million -3.4%N/A0 $44.45
4/30/202485,300 shares $3.79 million -59.3%N/A0 $44.45
4/15/2024209,600 shares $9.32 million -6.5%N/A2096 $44.45
3/31/2024224,100 shares $9.13 million +0.6%N/A0 $40.75
3/15/2024222,800 shares $9.08 million +3.3%N/A0 $40.75
2/29/2024215,600 shares $8.79 million -14.3%N/A0 $40.75
2/15/2024251,600 shares $10.25 million -9.1%N/A2516 $40.75
1/15/2024268,800 shares $11.02 million +3.0%N/A0 $41.00
12/31/2023260,900 shares $10.70 million +1.5%N/A0 $41.00
12/15/2023257,100 shares $10.54 million +2.0%N/A0 $41.00
11/30/2023252,100 shares $10.34 million -1.9%N/A0 $41.00
11/15/2023256,900 shares $10.53 million -0.7%N/A0 $41.00
10/31/2023258,800 shares $10.61 million -9.0%N/A2588 $41.00
10/15/2023284,400 shares $14.22 million -1.4%N/A0 $50.00
9/30/2023288,300 shares $14.42 million +7.5%N/A0 $50.00
9/15/2023268,300 shares $13.42 million -2.9%N/A0 $50.00
8/31/2023276,400 shares $13.82 million -9.2%N/A0 $50.00
8/15/2023304,300 shares $15.22 million +2.6%N/A0 $50.00
7/31/2023296,600 shares $14.83 million -12.1%N/A0 $50.00
7/15/2023337,300 shares $16.87 million -2.9%N/A0 $50.00
6/30/2023347,200 shares $17.36 million +4.0%N/A0 $50.00
6/15/2023333,900 shares $16.70 million -1.6%N/A3339 $50.00
5/31/2023339,200 shares $16.96 million +0.6%N/A3392 $50.00
5/15/2023337,300 shares $17.54 million -14.7%N/A3373 $52.00
4/30/2023395,600 shares $20.57 million +0.4%N/A0 $52.00
4/15/2023394,000 shares $20.49 million +0.5%N/A0 $52.00
3/31/2023392,200 shares $20.39 million +5.5%N/A0 $52.00
3/15/2023371,700 shares $19.33 million +0.5%N/A0 $52.00
2/28/2023369,700 shares $19.22 million -4.5%N/A0 $52.00
2/15/2023386,900 shares $20.12 million +3.6%N/A0 $52.00
626 winning trades out of 647… (Ad)

Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trader has done over the past 8 years—closing 647 trades, with an unbelievable 97% win rate. Now, for the first time, he's breaking his silence and revealing his personal technique for success.

Click here to watch our exclusive interview and uncover his personal technique
1/31/2023373,400 shares $19.42 million +1.3%N/A0 $52.00
1/15/2023368,800 shares $19.18 million -0.1%N/A0 $52.00
12/30/2022369,000 shares $19.19 million +0.2%N/A0 $52.00
12/15/2022368,300 shares $19.15 million -0.9%N/A0 $52.00
11/30/2022371,800 shares $19.33 million -2.2%N/A3718 $52.00
11/15/2022380,200 shares $17.49 million -0.1%N/A3802 $46.00
10/31/2022380,600 shares $15.60 million -3.7%N/A0 $41.00
10/15/2022395,100 shares $16.20 million -2.7%N/A0 $41.00
9/30/2022406,100 shares $16.65 million +0.5%N/A0 $41.00
9/15/2022404,200 shares $16.57 million +6.2%N/A4042 $41.00
8/31/2022380,700 shares $15.61 million -5.5%N/A0 $41.00
8/15/2022402,900 shares $16.52 million -21.8%N/A0 $41.00
7/31/2022515,400 shares $21.13 million -19.0%N/A0 $41.00
7/15/2022635,900 shares $26.07 million -1.9%N/A0 $41.00
6/30/2022648,000 shares $26.57 million -1.3%N/A0 $41.00
6/15/2022656,300 shares $26.91 million -2.0%N/A0 $41.00
5/31/2022669,900 shares $27.47 million -0.6%N/A0 $41.00
5/15/2022673,600 shares $27.62 million -0.3%N/A0 $41.00
4/30/2022675,600 shares $27.70 million +2.3%N/A0 $41.00
4/15/2022660,500 shares $27.08 million +4.2%N/A0 $41.00
3/31/2022634,000 shares $25.99 million -2.3%N/A0 $41.00
3/15/2022649,000 shares $26.61 million -1.2%N/A0 $41.00
2/28/2022656,900 shares $26.93 million +4.5%N/A0 $41.00
2/15/2022628,900 shares $25.78 million +0.5%N/A6289 $41.00
1/31/2022625,900 shares $25.66 million -1.2%N/A0 $41.00
1/15/2022633,200 shares $25.96 million -1.1%N/A0 $41.00
12/31/2021640,000 shares $26.24 million -2.8%N/A0 $41.00
12/15/2021658,300 shares $26.99 million +0.6%N/A6583 $41.00
11/30/2021654,300 shares $30.75 million +1.8%N/A0 $47.00
11/15/2021642,500 shares $30.20 million +17.1%N/A0 $47.00
10/29/2021548,700 shares $25.79 million +8.0%N/A0 $47.00
10/15/2021508,100 shares $23.88 million +0.8%N/A5081 $47.00
9/30/2021504,000 shares $23.18 million +5.1%N/A0 $46.00
9/15/2021479,400 shares $22.05 million -3.3%N/A0 $46.00
8/31/2021495,700 shares $22.80 million -4.1%N/A0 $46.00
8/13/2021516,600 shares $23.76 million -2.7%N/A0 $46.00
7/30/2021530,800 shares $24.42 million -6.3%N/A5308 $46.00
7/15/2021566,400 shares $28.21 million -1.7%N/A0 $49.80
6/30/2021576,400 shares $28.71 million -1.1%N/A5764 $49.80
6/15/2021582,600 shares $26.82 million -2.5%N/A0 $46.04
5/28/2021597,800 shares $27.52 million +0.7%N/A0 $46.04
5/14/2021593,500 shares $26.74 million -1.1%N/A5935 $45.05
4/30/2021600,100 shares $31.14 million -0.6%N/A6001 $51.89
4/15/2021603,400 shares $30.29 million -2.6%N/A6034 $50.20
3/31/2021619,400 shares $30.85 million -0.9%N/A6194 $49.80
3/15/2021625,200 shares $31.99 million +10.1%N/A6252 $51.16
2/26/2021567,800 shares $32.93 million +1.7%N/A5678 $58.00
2/12/2021558,100 shares $33.21 million +0.9%N/A0 $59.50
1/29/2021553,100 shares $32.91 million +0.9%N/A0 $59.50
1/15/2021550,300 shares $32.17 million -1.9%N/A5503 $58.46
626 winning trades out of 647… (Ad)

Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trader has done over the past 8 years—closing 647 trades, with an unbelievable 97% win rate. Now, for the first time, he's breaking his silence and revealing his personal technique for success.

Click here to watch our exclusive interview and uncover his personal technique
12/31/2020548,800 shares $33.11 million -0.3%N/A5488 $60.34
12/15/2020550,300 shares $32.63 million -1.9%N/A5503 $59.30
11/30/2020560,800 shares $33.31 million -2.9%N/A5608 $59.40
11/15/2020577,400 shares $31.18 million +2.0%N/A0 $54.00
10/30/2020566,000 shares $30.56 million +13.8%N/A5660 $54.00
10/15/2020497,200 shares $27.15 million -4.9%N/A4972 $54.60
9/30/2020522,600 shares $29.01 million -1.3%N/A0 $55.52
9/15/2020529,300 shares $29.39 million -1.0%N/A5293 $55.52
8/31/2020534,500 shares $29.68 million -2.5%N/A2672.5 $55.52
8/14/2020548,300 shares $30.41 million +5.9%N/A0 $55.47
7/31/2020517,800 shares $28.88 million +64.0%N/A0 $55.77
7/15/2020315,800 shares $17.61 million +0.9%N/A3158 $55.77
6/30/2020313,000 shares $15.89 million -1.2%N/A3130 $50.78
6/15/2020316,700 shares $16.66 million -1.6%N/A0 $52.60
5/29/2020321,700 shares $15.96 million -16.7%N/A3217 $49.60
5/15/2020386,400 shares $19.52 million -1.5%N/A0 $50.51
4/30/2020392,100 shares $19.80 million +4.1%N/A3921 $50.51
4/15/2020376,500 shares $18.84 million +0.2%N/A3765 $50.03
3/31/2020375,800 shares $14.00 million -18.6%N/A3758 $37.25
3/13/2020461,900 shares $20.46 million -13.7%N/A4619 $44.30
2/28/2020535,100 shares $23.70 million +5.0%N/A0 $44.30
2/14/2020509,500 shares $22.57 million -0.4%N/A0 $44.30
1/31/2020511,400 shares $30.48 million -0.6%N/A5114 $59.60
1/15/2020514,400 shares $30.66 million +1.5%N/A5144 $59.60
12/31/2019506,600 shares $30.19 million -2.1%N/A0 $59.60

BPMUF Short Interest - Frequently Asked Questions

What is Basilea Pharmaceutica's current short interest?

Short interest is the volume of Basilea Pharmaceutica shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 30,400 shares of BPMUF short. Learn More on Basilea Pharmaceutica's current short interest.

What is a good short interest ratio for Basilea Pharmaceutica?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BPMUF shares currently have a short interest ratio of 304.0. Learn More on Basilea Pharmaceutica's short interest ratio.

Is Basilea Pharmaceutica's short interest increasing or decreasing?

Basilea Pharmaceutica saw a decline in short interest during the month of October. As of October 15th, there was short interest totaling 30,400 shares, a decline of 0.3% from the previous total of 30,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Basilea Pharmaceutica's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Basilea Pharmaceutica: Amphastar Pharmaceuticals, Inc. (11.71%), CG Oncology, Inc. (14.81%), Twist Bioscience Co. (15.07%), Arrowhead Pharmaceuticals, Inc. (7.51%), Scholar Rock Holding Co. (18.66%), ACADIA Pharmaceuticals Inc. (4.93%), Harmony Biosciences Holdings, Inc. (24.29%), Vera Therapeutics, Inc. (14.89%), Longboard Pharmaceuticals, Inc. (15.34%), IDEAYA Biosciences, Inc. (12.55%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Basilea Pharmaceutica stock?

Short selling BPMUF is an investing strategy that aims to generate trading profit from Basilea Pharmaceutica as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Basilea Pharmaceutica?

A short squeeze for Basilea Pharmaceutica occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BPMUF, which in turn drives the price of the stock up even further.

How often is Basilea Pharmaceutica's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BPMUF, twice per month. The most recent reporting period available is October, 15 2024.




This page (OTCMKTS:BPMUF) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners